CPhI News

Suppliers’ Supply Chains and Continuous Manufacturing Pose Big Risks for US CDMOs

April 04, 2023

A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.

CPHI Awards Open for Entries in Multiple Categories

March 23, 2023

Three new awards have been added to the roster for 2023 and include some specific highlights that have occurred over the past few years.

Steriline Showcases Filling Equipment at CPHI 2022

November 02, 2022

Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.

CPHI 2022 Award Winners Announced

November 02, 2022

The winners of the 2022 CPHI Excellence in Pharma Awards were announced on Nov. 1, 2022 at an awards ceremony in Frankfurt, Germany.

Terumo Pharmaceutical Solutions Expands CDMO Services

November 01, 2022

The company is expanding its contract development and manufacturing services for parenteral drugs to global customers.

CPHI Pharma Index Indicates Record High for Global Pharma Confidence

November 01, 2022

Metrics from the CPHI Annual Survey suggest that confidence in the global pharma market has risen significantly in the past year.

Purolite and Repligen Announce Ligand Partnership

November 01, 2022

Purolite and Repligen have extended their existing ligand partnership through 2032.

Lonza Launches New Capsule Solution for Intestinal Drug Delivery

November 01, 2022

Lonza has launched a new capsule to deliver acid-sensitive APIs to the intestine.

Ashland Injectable Pharmaceutical Excipient Accepted into FDA Novel Excipient Review Pilot Program

November 01, 2022

FDA has accepted Ashland’s Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient into the FDA Novel Excipient Review Pilot Program.

Gerresheimer Showcases DropControl, a New Dropper Solution for Ophthalmic Formulations, at CPHI 2022

November 01, 2022

Gerresheimer has developed a new dropper insert for ophthalmic formulations that it is showcasing at CPHI 2022 in Frankfurt, Germany.